Veradigm Net Long-Term Debt 2010-2022 | MDRX
Veradigm net long-term debt from 2010 to 2022. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
| Veradigm Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $201 |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $0 |
| 2015 | $-1 |
| 2014 | $0 |
| 2013 | $336 |
| 2012 | $-1 |
| 2011 | $-1 |
| 2010 | $-1 |
| 2010 | $-2 |
| 2009 | $-12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.476B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.064B | 58.60 |
| Hims & Hers Health (HIMS) | United States | $13.260B | 137.77 |
| Tempus AI (TEM) | United States | $12.137B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.628B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.753B | 58.64 |
| Hinge Health (HNGE) | United States | $2.965B | 0.00 |
| Privia Health (PRVA) | United States | $2.730B | 186.58 |
| Enovis (ENOV) | United States | $1.764B | 9.83 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Phreesia (PHR) | United States | $1.519B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.342B | 62.36 |
| Omnicell (OMCL) | United States | $1.335B | 23.55 |
| 10x Genomics (TXG) | United States | $1.300B | 0.00 |
| Claritev (CTEV) | United States | $0.661B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.544B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 142.50 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.348B | 771.33 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| American Well (AMWL) | United States | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.099B | 3.79 |
| MDxHealth SA (MDXH) | Belgium | $0.093B | 0.00 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |